Detalhe da pesquisa
1.
Extended letermovir administration, beyond day 100, is effective for CMV prophylaxis in patients with graft versus host disease.
Transpl Infect Dis
; 23(2): e13487, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33034124
2.
KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells.
Blood
; 119(6): 1450-8, 2012 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22144178
3.
Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation.
Leuk Lymphoma
; 65(4): 493-502, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164945
4.
Final Outcomes from a Phase 2 Trial of Posoleucel in Allogeneic Hematopoietic Cell Transplant Recipients.
Blood Adv
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593233
5.
Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.
Transpl Immunol
; 84: 102039, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513813
6.
Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review.
Leuk Lymphoma
; 64(2): 273-282, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282773
7.
"Waitlist mortality" is high for myeloma patients with limited access to BCMA therapy.
Front Oncol
; 13: 1206715, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601685
8.
Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients.
Leuk Lymphoma
; 64(12): 1981-1991, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574842
9.
Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis.
Clin Lymphoma Myeloma Leuk
; 23(3): 178-187, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682989
10.
Quantitative proliferation dynamics and random chromosome segregation of hair follicle stem cells.
EMBO J
; 27(9): 1309-20, 2008 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18401343
11.
Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation.
Transplant Cell Ther
; 28(3): 135-144, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34958974
12.
Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access.
Transplant Cell Ther
; 28(7): 358-364, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429662
13.
Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis.
Front Oncol
; 12: 1005042, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36276084
14.
Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Front Immunol
; 13: 1005031, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263054
15.
Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysis.
Leuk Lymphoma
; 63(11): 2671-2678, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687838
16.
Isolated thrombocytopenia and liver function abnormalities characterizing an atypical presentation of thrombotic thrombocytopenic purpura.
Ann Hematol
; 95(12): 2079-2080, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542956
17.
Revving the CAR - Combination strategies to enhance CAR T cell effectiveness.
Blood Rev
; 45: 100695, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402724
18.
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Transplant Cell Ther
; 27(9): 796.e1-796.e7, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34256172
19.
Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding.
J Clin Exp Hepatol
; 11(3): 327-333, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33519132
20.
Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 59(1): 134-137, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833526